![]() |
市場調查報告書
商品編碼
2050422
全球牙科骨移植替代物及其他生物材料市場:市場規模、佔有率和趨勢分析(2026-2032年)Dental Bone Graft Substitute and Other Biomaterials Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Dental Bone Graft Substitutes, Dental Barrier Membranes, and Local Antimicrobial Periodontal Treatments |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2025年,全球牙科骨移植替代物和其他生物材料的市值為23.3億美元。預計未來將以7.2%的年複合成長率成長,到2032年將達到近38億美元。
這份綜合報告涵蓋了牙科骨移植替代物、牙科屏障膜、局部抗菌牙周治療和牙科創傷護理。這些統稱為牙科生物材料市場。
該分析包括銷售量、平均售價(ASP)、市場規模、成長趨勢、市場促進因素和限制因素、截至2032年的市場預測以及截至2022年的歷史資料。還涵蓋了近期併購、公司簡介、產品系列和主要參與者。
該市場的成長與全球人工植牙市場密切相關。隨著植入應用率的提高,越來越多的患者需要植骨來解決骨量不足或骨質疏鬆的問題,因此對牙科骨移植替代物及相關生物材料的需求預計將會上升。
市場概覽
全球牙科骨移植替代物及其他生物材料市場涵蓋用於支持口腔組織再生、植入位點製備和牙周治療的產品。這些產品在植入和修復牙科學中發揮著非常重要的作用,尤其是在治療前或治療過程中需要骨骼或軟組織支撐時。
牙科骨移植替代物是市場的重要組成部分。這些產品用於齒槽窩保存、上顎竇提升術、齒槽骨增高術和牙周治療。由於許多植入候選者在植牙前需要進行骨移植,因此這些產品的需求與植入手術的數量密切相關。
牙科屏障膜在誘導骨再生中也扮演重要角色。這些產品有助於保護移植部位,促進組織分離,並改善再生效果。可吸收和不可吸收膜的創新發展,正推動先進材料在更複雜的手術中得到應用。
該市場還包括局部抗菌牙周治療產品和牙科軟組織創傷護理產品。這些細分市場共同支持更廣泛的再生和外科手術流程。成長的促進因素包括植入的日益普及、牙科基礎設施的改善、牙醫培訓計畫的加強以及患者對功能性和美觀性治療效果日益成長的期望。
市場促進因素
牙科生物材料市場的主要驅動力之一是牙科專業人員經驗的累積。進行骨頭移植術的牙科專家越來越熟悉臨床工作流程,並對可用的材料選擇有了更深入的了解。這有助於提高治療方案製定和患者溝通的信心。
隨著臨床醫生經驗的積累,他們越來越傾向於使用更先進、更昂貴的產品。例如,為了滿足更高級的植骨需求,可以選擇混合型同種異體骨(結合了皮質骨和鬆質骨)、含有鈣化骨碎片的脫鈣骨基質(DBM)以及鈦增強屏障膜等產品。這既提高了手術品質,也促進了市場價值的成長。
技術進步和產品多樣化也支持了市場需求。屏障膜在易操作性、強度和臨床應用方面均有所改善。鈦增強膜拓展了複雜手術的應用範圍,而新的設計和抗菌概念則幫助製造商在競爭激烈的市場中更有理由提高價格,並緩解價格壓力。
市場限制
口腔健康狀況的改善將成為牙骨移植市場長期發展的限制因素。在許多地區,由於口腔衛生意識的提高、牙科檢查頻率的增加以及預防保健的改善,無牙顎的發生率下降。未來,隨著人口老化,人們的牙齒狀況將比前幾代人更好,這可能會在某些市場縮小需要大規模植骨手術的潛在患者群體。
大規模骨移植手術也是市場的限制因素。例如,齒槽骨增容手術可能需要5毫升至10毫升的移植材料,這會導致治療費用高昂。在某些情況下,移植手術本身的費用甚至可能超過植入治療的費用,對患者造成經濟負擔。
在低收入地區和對醫療成本高度敏感的環境中,患者的經濟能力尤其重要。即使患者的臨床表現符合植入或骨移植的指徵,經濟拮据也可能導致他們延遲治療、選擇成本較低的替代方案,甚至完全放棄治療。這限制了臨床需求轉化為實際手術。
市場覆蓋範圍和資料範圍
本報告目的是幫助讀者評估植入手術數量增加、移植需求、醫療保健專業人員培訓、產品創新以及患者經濟負擔等因素對全球牙科生物材料市場的影響。
目標市場及區隔
依應用進行細分僅在單元層級進行分析。
該市場包含在更廣泛的牙科生物材料報告系列中。
透過市場規模、市場佔有率、市場預測、市場成長率、銷售量和平均售價等相關定量指標對每個細分市場進行分析。
競爭分析
2025年,Geistlich Pharma繼續保持在全球牙科骨移植替代物和牙科生物材料市場的領先地位。該公司在牙科骨移植替代物(DBGS)和牙科屏障膜領域均佔據顯著的市場佔有率。其牛源異種移植骨「Bio-Oss®」和膠原蛋白膜產品線「Bio-Gide®」廣泛應用於誘導谷再生手術,鞏固了該公司在再生牙科領域的領先地位。
此外,Geistlich透過一系列策略舉措鞏固了其市場地位,例如2024年收購Bionnovation Biomedical,2025年投資著重患者個體化再生解決方案的ReOss,以及持續拓展其再生醫學產品組合。儘管面臨來自低成本、本地採購的異種移植材料和膠原蛋白膜產品的日益激烈的競爭,Geistlich預計在整個預測期內仍將保持強勁的市場地位。
到了2025年,Henry Schein鞏固其在全球牙科骨移植材料市場的第二大競爭者地位。該公司的市場地位主要得益於其專業品牌BioHorizons和ACE Southern。 BioHorizons提供豐富的再生醫學產品組合,包括MinerOss®、Grafton® DBM和LADDEC®;而ACE Southern則增強了Henry Schein企業發展在外科和種植耗材領域的業務實力。
ZimVie在2025年仍保持主要競爭對手的地位。其用於再生醫學的生物材料產品組合包括同種異體移植片、異質骨移植、合成移植片和屏障膜,產品包括Puros® Allograft、RegenerOss®和Endobon®等。在2025年被ARCHIMED收購後,ZimVie有望在人工植牙和再生醫學生物材料領域的投資方面獲得更多支持。
技術和臨床趨勢
人工植牙的成長持續推動著牙科生物材料市場的發展。由於許多植入手術需要植骨來解決骨量或骨質不足的問題,因此對牙科生物材料(DBGS)的需求與植入手術的數量密切相關。
隨著臨床醫生經驗的積累,高品質的移植材料越來越受到關注。當臨床醫生尋求更便利的操作、更佳的性能或更柔軟性的臨床應用時,會使用更先進的同種異體骨混合物、脫鈣骨基質(DBM)糊劑和專用再生材料。
屏障膜的創新仍然非常重要。鈦增強膜拓展了其在複雜誘導骨再生手術中的應用範圍,而新的設計則提高了操作便利性和臨床療效。
不可吸收膜技術不斷發展。例如,ZimVie 的OsseoGuard® 不可吸收膜等產品目的是防止細菌入侵,這反映出人們對能夠有效保護和促進手術區域再生的產品持續保持高度關注。
以患者為中心的個人化再生解決方案正逐漸成為長期趨勢。對客製化再生技術的投資表明,供應商尋求提高先進移植手術的適配性、精準度和臨床規劃的方法。
價格壓力依然存在。越來越多的區域性製造商提供價格較低的異質骨移植和膠原蛋白膜產品,加劇了市場競爭,尤其是在對價格敏感的市場。高階品牌必須繼續透過臨床證據、產品品質和醫療專業人員的信任來證明其高價位的合理性。
地區
本報告涵蓋全球調查區域,包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。
目前全球牙科骨移植替代物及其他生物材料市場規模有多大?預計到2032年將如何成長?
牙科骨移植替代物、屏障膜、抗菌牙周治療和創傷護理產品在全球市場的表現如何?
銷售量、平均售價和市場規模如何隨時間變化?
人工植牙量的增加對骨移植材料的需求有何影響?
包括同種移植材料、異種移植材料和複合材料在內,哪些類型的移植材料最受關注?
屏障膜的技術進步對引導骨再生(GBR)手術有何影響?
從業者經驗、產品多樣性和高品質生物材料在市場成長中發揮什麼作用?
牙科護理品質的提升和高昂的治療費用如何限制長期需求?
牙科生物材料市場的主要參與者有哪些? Geistlich Pharma、Henry Schein 和 ZimVie 在其中扮演什麼角色?
iData Research 的《全球牙科骨移植替代物及其他生物材料市場報告》透過詳盡的市場規模、平均售價(ASP)趨勢、預測和競爭格局分析,解答了上述問題。本報告可用於評估需求、對標主要競爭對手、了解技術應用現狀,並制定全球牙科生物材料市場的成長策略。
圖表一覽
執行摘要
全球牙科骨移植材料及其他生物材料市場概覽
競爭分析
市場趨勢
市場趨勢
目標市場
目標區域
關鍵分析的最新進展
主要報告更新
版本歷史記錄
調查方法
全球牙科骨移植材料及其他生物材料市場概覽
The global dental bone graft substitute and other biomaterials market was valued at $2.33 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 7.2%, reaching nearly $3.8 billion by 2032.
This comprehensive report covers dental bone graft substitutes, dental barrier membranes, local antimicrobial periodontal treatments and dental wound care. Collectively, these segments are referred to as the dental biomaterials market.
The analysis includes unit sales, average selling prices (ASPs), market size, growth trends, market drivers and limiters, market forecasts through 2032, and historical data back to 2022. It also includes recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
Growth in this market is closely tied to the global dental implant market. As implant adoption increases and more patients require grafting to address insufficient bone volume or quality, demand for dental bone graft substitutes and related biomaterials is expected to rise.
Market Overview
The global dental bone graft substitute and other biomaterials market includes products used to support oral tissue regeneration, implant site preparation and periodontal treatment. These products play an important role in implant dentistry and restorative dental care, especially when bone or soft tissue support is needed before or during treatment.
Dental bone graft substitutes represent a core part of the market. These products are used in socket preservation, sinus augmentation, ridge augmentation and periodontal procedures. Their demand is strongly connected to implant procedure volume because many implant candidates require grafting before placement.
Dental barrier membranes are also important in guided bone regeneration. These products help protect the graft site, support tissue separation and improve regenerative outcomes. Product innovation in resorbable and non-resorbable membranes has supported the use of advanced materials in more complex procedures.
The market also includes local antimicrobial periodontal treatments and dental soft tissue wound care products. Together, these segments support broader regenerative and surgical workflows. Growth is supported by rising implant adoption, improving dental infrastructure, better practitioner training and increasing patient expectations for functional and aesthetic outcomes.
Market Drivers
An increase in practitioner experience is a major driver of the dental biomaterials market. Dental professionals who perform bone grafting procedures are becoming more comfortable with clinical workflows and more aware of the material options available to them. This has increased confidence in treatment planning and patient communication.
As clinicians gain experience, they are more likely to use advanced and premium-priced products. Hybrid cortical-cancellous allograft mixtures, DBM putties with mineralized bone chips and titanium-reinforced barrier membranes are examples of products that may be selected for more sophisticated grafting needs. This supports both procedure quality and market value growth.
Technological improvements and greater product variety are also supporting demand. Barrier membranes have improved in handling, strength and clinical application. Titanium-reinforced membranes have expanded the possibilities for complex procedures, while newer designs and bacterial-resistant concepts help manufacturers justify higher price points and reduce pricing pressure in a competitive market.
Market Limiters
Improving dental health is a long-term limiter for the dental bone graft substitute market. In many regions, greater awareness of oral health, more frequent dental checkups and better preventive care are reducing the rate of edentulism. As future aging populations retain better dentition than previous generations, the potential pool of patients requiring extensive grafting may shrink in certain markets.
Large bone grafting procedures are another limiter. Procedures such as ridge augmentation can require 5 cc to 10 cc of grafting material, which can make treatment expensive. In some cases, the grafting procedure itself may cost more than receiving a dental implant, creating a financial barrier for patients.
Patient affordability is especially important in lower-income regions and cost-sensitive healthcare settings. Even when patients are clinically eligible for implant and grafting procedures, financial constraints may lead them to delay treatment, choose less expensive alternatives or avoid treatment altogether. This limits the conversion of clinical need into actual procedure volume.
Market Coverage and Data Scope
The report is designed to help readers evaluate how implant procedure growth, grafting needs, practitioner training, product innovation and patient affordability are shaping the global dental biomaterials market.
Markets Covered and Segmentation
Application segmentation is analyzed at a unit level only.
This market is included as part of the broader dental biomaterials report suite.
Each segment is analyzed through relevant quantitative measures, including market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
Competitive Analysis
Geistlich Pharma remained a leading competitor in the global dental bone graft substitute and dental biomaterials market in 2025. The company held significant shares in both the DBGS and dental barrier membrane segments. Its Bio-Oss(R) bovine xenograft and Bio-Gide(R) collagen membrane product lines are widely used in guided bone regeneration procedures, supporting its strong regenerative dentistry position.
Geistlich has also strengthened its market presence through strategic developments, including the 2024 acquisition of Bionnovation Biomedical, a 2025 investment in ReOss focused on patient-specific regenerative solutions and continued expansion of its regenerative portfolio. Despite rising competition from lower-priced regional xenograft and collagen membrane products, Geistlich is expected to maintain a strong position over the forecast period.
Henry Schein strengthened its position as the second-largest global competitor in the dental bone graft substitute market in 2025. Its position is driven primarily by specialty brands such as BioHorizons and ACE Southern. BioHorizons offers a broad regenerative portfolio, including MinerOss(R), Grafton(R) DBM and LADDEC(R), while ACE Southern strengthens Henry Schein's reach in surgical and grafting consumables.
ZimVie also remained a leading competitor in 2025. Its regenerative biomaterials portfolio includes allografts, xenografts, synthetic grafts and barrier membranes, supported by products such as Puros(R) Allograft, RegenerOss(R) and Endobon(R). Following its 2025 acquisition by ARCHIMED, ZimVie is expected to receive further support for investment in dental implants and regenerative biomaterials.
Technology and Practice Trends
Dental implant growth continues to shape the dental biomaterials market. Because many implant procedures require grafting to address insufficient bone volume or quality, DBGS demand is closely tied to implant procedure volume.
Premium grafting materials are gaining attention as clinician experience increases. More advanced allograft mixtures, DBM putties and specialized regenerative materials are being used in cases where clinicians seek improved handling, performance or clinical flexibility.
Barrier membrane innovation remains important. Titanium-reinforced membranes have expanded the ability to support complex guided bone regeneration procedures, while newer designs improve handling and clinical efficiency.
Non-resorbable membranes continue to evolve. Products such as ZimVie's OsseoGuard(R) non-resorbable membrane are designed to address bacterial infiltration, reflecting continued interest in products that support site protection and regenerative success.
Patient-specific regenerative solutions are emerging as a longer-term trend. Investments in customized regenerative technologies suggest that suppliers are seeking ways to improve fit, precision and clinical planning in advanced grafting procedures.
Pricing pressure remains relevant. Regional manufacturers offering lower-priced xenograft and collagen membrane products are increasing competition, especially in cost-sensitive markets. Premium brands must continue to justify higher price points through clinical evidence, product quality and practitioner trust.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
How large is the global dental bone graft substitute and other biomaterials market, and how is it expected to grow through 2032?
How are dental bone graft substitutes, barrier membranes, antimicrobial periodontal treatments and wound care products performing across global markets?
How are unit sales, average selling prices and market values changing over time?
How does growth in dental implant procedures affect demand for bone graft substitutes?
Which graft materials are gaining traction, including allografts, xenografts and synthetic options?
How are barrier membrane innovations affecting guided bone regeneration procedures?
What role do practitioner experience, product variety and premium biomaterials play in market growth?
How do improving dental health and high procedure costs limit long-term demand?
Which companies lead the dental biomaterials market, and how are Geistlich Pharma, Henry Schein and ZimVie positioned?
The Global Dental Bone Graft Substitute and Other Biomaterials Market Report from iData Research answers these questions with detailed market sizing, ASP trends, forecasts and competitive share insights. Use it to evaluate demand, benchmark leading competitors, understand technology adoption and plan for growth across the global dental biomaterials market.
List of Figures
List of Charts
executive summary
Global Dental Bone Graft Substitute and Other Biomaterials Market Overview
Competitive Analysis
Market Trends
Market Developments
Markets Included
Regions Included
Key Analysis Updates
Key Report Updates
Version History
research methodology
Global Dental Bone Graft Substitute and Other Biomaterials Market Overview